SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Tech Stock Options
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Perfect Hedge who wrote (40899)4/22/1998 11:36:00 PM
From: Dwight E. Karlsen  Read Replies (2) of 58727
 
beebs, think about it: In any ongoing clinical trial, you're going to have a certain number of trial particants die while the clinical trial is going on. Heart-attack, brain aneurism, etc. Doesn't mean the drug they were taking was the cause of death. If an autopsy revealed that the deaths were the result of something unexplained, believe me there's no way pfizer would go ahead and issue pills that could cause unexplained death in a random small number of users. They're not quite that dumb.

Plus, one would think that the FDA wouldn't say "oh, well you only had a couple of unexplainable deaths during the clinical trials. It's a go". Rubbish.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News